Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Medicaid Managed Care topic
No spam. Unsubscribe anytime.
Nevada Health Authority seeks higher managed‑care rates, funds to shore up PRTF oversight
Summary
Health authority leaders told the committee rising medical and pharmacy costs required a double‑digit rate increase for calendar year 2026 and asked for hospital provider assessment and federal funds to improve licensing and oversight of psychiatric residential treatment facilities for children.
The Nevada Health Authority asked the Interim Finance Committee for funding to strengthen oversight of psychiatric residential treatment facilities (PRTFs) and to support calendar‑year 2026 managed care rate increases.
Stacy Weeks, NHA director, said medical trend, behavioral‑health utilization and pharmacy cost pressures drove the need for a 10.4% overall increase from CY2025 to CY2026; the agency used updated trend assumptions (base annualized trend ~6%) and added policy and fee schedule adjustments. Weeks said federal actuarial standards require rates to be ‘‘actuarially sound’’ and that an insufficient rate would risk provider network strain and member access. The agency described a negotiated risk corridor and medical loss ratio (MLR) protections that allow mid‑year reconciliation and recoupment if plans underspend on medical care.
NHA requested $743,441 to hire contractors to improve licensing, policy, and oversight for PRTFs and explained how contracted consultants will help identify unlicensed operators, strengthen state enforcement and align licensing with DOJ settlement obligations and Medicaid reimbursement. Committee members asked whether the work would identify and refer unlicensed providers to legal enforcement; Weeks said the vendor will review state law, model other states’ approaches and recommend enforcement options.
Committee action: Following Q&A, the committee approved the licensing/contract work program. Members asked for mid‑year monitoring and requested memos from MCOs describing cost‑containment strategies for later review.
